Authors
Latest:
Enrollment: More Than NumbersPartnering with CROs and using a blinded independent central review can increase trial success.
Latest:
PK in Late Phase TrialsCollecting PK data in late phase trials led to alleviating additional trials, drug approval, and better dosing.
Latest:
Re-Imagining CTMSClinical professionals can recreate CTMS by applying modern technology in a new way.
Latest:
The Observation Study ConundrumConducting observational studies is becoming a vital part of the clinical trial process, but research teams often struggle to operationalize these more creative and non-traditional study methodologies.
Latest:
Language & Culture in Global Clinical TrialsWith more clinical trials conducted overseas, sponsors are facing new obstacles.
Latest:
Pharmacovigilance AlliancesThe best relationships between sponsors and contractors are those that are well defined from the outset.
Latest:
PK in Late Phase TrialsCollecting PK data in late phase trials led to alleviating additional trials, drug approval, and better dosing.
Latest:
Bridging US and China to Conquer CancerDuring the annual ASCO meeting in June, the US Chinese Anti-Cancer Association (USCACA) held its fourth annual meeting to discuss the emerging role of China in global clinical development of novel anti-cancer drugs.
Latest:
Enrollment: More Than NumbersPartnering with CROs and using a blinded independent central review can increase trial success.
Latest:
PK in Late Phase TrialsCollecting PK data in late phase trials led to alleviating additional trials, drug approval, and better dosing.
Latest:
Bridging US and China to Conquer CancerDuring the annual ASCO meeting in June, the US Chinese Anti-Cancer Association (USCACA) held its fourth annual meeting to discuss the emerging role of China in global clinical development of novel anti-cancer drugs.
Latest:
Emerging Opportunity in GuatemalaGuatemala is multi-ethnic, multilingual, and multi-cultural-ideal for international trials.
Latest:
PK in Late Phase TrialsCollecting PK data in late phase trials led to alleviating additional trials, drug approval, and better dosing.
Latest:
My 3 Key Reflections on Partnerships in Clinical Trials USA 2016Technology advancement has been breaking down traditional barriers and has provided an answer to how the industry can move forward. The Partnerships in Clinical Trials Conference in Boston drove home this approach with three key themes that were present at the event.
Latest:
Electronic Endpoint AdjudicationHow an integrated, EDC-based system can optimize the endpoint process.
Latest:
Rethinking Document SharingThe benefits of peer-to-peer networking over email, fax, FTP, and hosted solutions.
Latest:
Beware of Costly ConsequencesNoncompliance with the US Foreign Corrupt Practices Act carries heavy penalties.
Latest:
Reducing Risk Through Mitigation StrategiesProactive risk management helps pharma protect their product development investments and future.
Latest:
Reducing Risk Through Mitigation StrategiesProactive risk management helps pharma protect their product development investments and future.
Latest:
Oh No Not Again...Investigator training should not be a "one-off" session at the start of clinical trial.
